Update: 10.04.2024
Last week: 13 week 2024 (25.03.2024 - 31.03.2024)
Last full month: March 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 356 | -10.2% | 9.8% | -0.6 | 16 587 782 | -9.9% | 8.3% | -0.5 | -4.4% |
| MoM | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| YTD | 90 243 | 23.8% | 10.9% | 2.3 | 202 768 376 | 55.4% | 9.4% | 2.2 | -2.1% |
| MAT | 358 211 | 33.8% | 9.7% | 1.7 | 729 075 069 | 48.3% | 8.2% | 1.4 | 10.2% |
| BRAINMAX | |||||||||
| WoW | 1 084 | -8.6% | 100.0% | 0 | 3 900 497 | -10.8% | 100.0% | 0 | -8.6% |
| MoM | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| YTD | 12 926 | 60.2% | 100.0% | 0 | 46 634 188 | 71.1% | 100.0% | 0 | 60.2% |
| MAT | 51 509 | 182.2% | 100.0% | NA | 180 374 665 | 200.5% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 18 428 | 1.9% | 45.7% | 1.7 | 57 068 593 | 1.3% | 36.7% | 1.7 | -1.8% |
| MoM | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| YTD | 215 400 | 2.7% | 44.0% | 2 | 689 072 651 | 9.3% | 36.0% | -2.1 | -2.0% |
| MAT | 874 723 | 20.0% | 45.4% | 2.1 | 2 750 082 651 | 29.2% | 39.1% | 1.1 | 14.4% |
| MIGRENIUM | |||||||||
| WoW | 11 405 | -2.1% | 0.5% | 0 | 3 537 819 | -1.2% | 0.7% | 0 | -1.4% |
| MoM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| YTD | 155 645 | -2.6% | 0.5% | -0.1 | 44 253 224 | 53.9% | 0.6% | 0.1 | 21.9% |
| MAT | 637 448 | 8.4% | 0.5% | 0 | 138 171 011 | 29.8% | 0.5% | 0 | 16.3% |
| MODELAX-N | |||||||||
| WoW | 37 817 | 3.1% | 27.8% | 1 | 15 804 477 | 3.0% | 17.9% | 0.6 | -0.4% |
| MoM | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| YTD | 413 998 | 62.4% | 23.5% | 6 | 169 120 904 | 109.1% | 14.6% | 4.6 | 20.8% |
| MAT | 1 327 112 | 117.7% | 20.2% | 8.6 | 471 058 755 | 134.4% | 11.6% | 5 | 24.7% |
| REDUXIN | |||||||||
| WoW | 12 884 | -7.3% | 32.0% | -1.9 | 71 641 496 | -8.2% | 46.1% | -2.4 | -1.8% |
| MoM | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| YTD | 162 801 | -7.1% | 33.3% | -1.8 | 886 642 664 | 24.3% | 46.4% | 3.3 | -2.0% |
| MAT | 625 428 | 3.4% | 32.5% | -3.5 | 3 046 599 756 | 21.4% | 43.3% | -1.6 | 14.4% |
| REDUXIN FORTE | |||||||||
| WoW | 3 327 | -2.4% | 8.3% | -0.1 | 14 346 610 | -0.3% | 9.2% | 0.3 | -1.8% |
| MoM | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| YTD | 42 608 | 7.6% | 8.7% | 0.8 | 187 420 251 | 27.5% | 9.8% | 0.9 | -2.0% |
| MAT | 169 031 | 31.5% | 8.8% | 1.1 | 693 921 592 | 42.3% | 9.9% | 1.1 | 14.4% |
| SALVISAR | |||||||||
| WoW | 12 121 | -0.9% | 1.6% | 0 | 4 846 653 | 0.9% | 1.4% | 0 | -0.8% |
| MoM | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
| YTD | 120 911 | -15.0% | 1.2% | -0.3 | 45 426 048 | -0.9% | 1.1% | -0.3 | 7.6% |
| MAT | 477 094 | -21.3% | 1.2% | -0.4 | 163 358 349 | -20.9% | 1.0% | -0.4 | 8.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 90 243 | 23.8% | 10.9% | 2.3 | 202 768 376 | 55.4% | 9.4% | 2.2 | -2.1% |
| BRAINMAX | 12 926 | 60.2% | 100.0% | 0 | 46 634 188 | 71.1% | 100.0% | 0 | 60.2% |
| GOLDLINE PLUS | 215 400 | 2.7% | 44.0% | 2 | 689 072 651 | 9.3% | 36.0% | -2.1 | -2.0% |
| MIGRENIUM | 155 645 | -2.6% | 0.5% | -0.1 | 44 253 224 | 53.9% | 0.6% | 0.1 | 21.9% |
| MODELAX-N | 413 998 | 62.4% | 23.5% | 6 | 169 120 904 | 109.1% | 14.6% | 4.6 | 20.8% |
| REDUXIN CAPS | 162 801 | -7.1% | 33.3% | -1.8 | 886 642 664 | 24.3% | 46.4% | 3.3 | -2.0% |
| REDUXIN FORTE | 42 608 | 7.6% | 8.7% | 0.8 | 187 420 251 | 27.5% | 9.8% | 0.9 | -2.0% |
| SALVISAR | 120 911 | -15.0% | 1.2% | -0.3 | 45 426 048 | -0.9% | 1.1% | -0.3 | 7.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 358 211 | 33.8% | 9.7% | 1.7 | 729 075 069 | 48.3% | 8.2% | 1.4 | 10.2% |
| BRAINMAX | 51 509 | 182.2% | 100.0% | NA | 180 374 665 | 200.5% | 100.0% | NA | NA |
| GOLDLINE PLUS | 874 723 | 20.0% | 45.4% | 2.1 | 2 750 082 651 | 29.2% | 39.1% | 1.1 | 14.4% |
| MIGRENIUM | 637 448 | 8.4% | 0.5% | 0 | 138 171 011 | 29.8% | 0.5% | 0 | 16.3% |
| MODELAX-N | 1 327 112 | 117.7% | 20.2% | 8.6 | 471 058 755 | 134.4% | 11.6% | 5 | 24.7% |
| REDUXIN CAPS | 625 428 | 3.4% | 32.5% | -3.5 | 3 046 599 756 | 21.4% | 43.3% | -1.6 | 14.4% |
| REDUXIN FORTE | 169 031 | 31.5% | 8.8% | 1.1 | 693 921 592 | 42.3% | 9.9% | 1.1 | 14.4% |
| SALVISAR | 477 094 | -21.3% | 1.2% | -0.4 | 163 358 349 | -20.9% | 1.0% | -0.4 | 8.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 356 | -10.2% | 9.8% | -0.6 | 16 587 782 | -9.9% | 8.3% | -0.5 | -4.4% |
| BRAINMAX | 1 084 | -8.6% | 100.0% | 0 | 3 900 497 | -10.8% | 100.0% | 0 | -8.6% |
| GOLDLINE PLUS | 18 428 | 1.9% | 45.7% | 1.7 | 57 068 593 | 1.3% | 36.7% | 1.7 | -1.8% |
| MIGRENIUM | 11 405 | -2.1% | 0.5% | 0 | 3 537 819 | -1.2% | 0.7% | 0 | -1.4% |
| MODELAX-N | 37 817 | 3.1% | 27.8% | 1 | 15 804 477 | 3.0% | 17.9% | 0.6 | -0.4% |
| REDUXIN CAPS | 12 884 | -7.3% | 32.0% | -1.9 | 71 641 496 | -8.2% | 46.1% | -2.4 | -1.8% |
| REDUXIN FORTE | 3 327 | -2.4% | 8.3% | -0.1 | 14 346 610 | -0.3% | 9.2% | 0.3 | -1.8% |
| SALVISAR | 12 121 | -0.9% | 1.6% | 0 | 4 846 653 | 0.9% | 1.4% | 0 | -0.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| BRAINMAX | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| GOLDLINE PLUS | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| MIGRENIUM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| MODELAX-N | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| REDUXIN CAPS | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| REDUXIN FORTE | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| SALVISAR | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs